Enhanced 3-Dimensional Lung-Like Epithelium Formation Systems and Methods

The present inventive concept relates to improved systems and methods for obtaining 3-dimensional lung-like epithelium, enhancing efficiency, scalability, and safety of lung tissue production for research, therapeutic, and transplantation applications.

The original patent disclosed methods and systems for growing 3-dimensional lung-like epithelium, but had limitations in terms of culturing conditions, growth factor optimization, and scalability. The present inventive concept addresses these limitations by introducing controlled bioreactors, optimized growth factor cocktails, and large-scale production capabilities, thereby improving the efficiency, quality, and safety of lung tissue production.

The new inventive concept comprises a system for obtaining 3-dimensional lung-like epithelium, featuring a bioreactor configured to culture cells from NKX2.1+ ventral-anterior foregut spheroid tissue derived from pluripotent stem cells, with controlled oxygen levels and temperature. Additionally, the inventive concept includes methods for enhancing efficiency, scaling up production, and real-time monitoring of 3-dimensional lung-like epithelium formation. These methods involve culturing cells in optimized growth factor cocktails, large-scale bioreactors, and microfluidic devices integrated with sensors and imaging systems.

The new inventive concept introduces novel and non-obvious improvements over the original patent, including the use of controlled bioreactors, optimized growth factor cocktails, and large-scale production capabilities, which significantly enhance the efficiency, quality, and safety of lung tissue production.

Alternative embodiments of the inventive concept may include the use of different types of bioreactors, growth factor cocktails, or microfluidic devices. Variations may also include the integration of additional sensors or imaging systems to monitor 3-dimensional lung-like epithelium formation.

The inventive concept has significant commercial potential in the fields of regenerative medicine, tissue engineering, and biomedical research, with potential applications in lung disease modeling, drug discovery, and transplantation therapy.